Valproic acid and Monocyte count increased - a phase IV clinical study of FDA data
Summary:
Monocyte count increased is reported as a side effect among people who take Valproic acid (valproic acid), especially for people who are female, 20-29 old, also take Clozaril, and have Schizophrenia.
The phase IV clinical study analyzes which people have Monocyte count increased when taking Valproic acid. It is created by eHealthMe based on reports of 35,830 people who have side effects when taking Valproic acid from the FDA, and is updated regularly.
What is Valproic acid?
Valproic acid has active ingredients of valproic acid. It is often used in epilepsy. eHealthMe is studying from 36,193 Valproic acid users. Check the latest studies of Valproic acid.
What is Monocyte count increased?
Monocyte count increased is found to be associated with 604 drugs and 690 conditions by eHealthMe. Check the latest studies of Monocyte count increased.
35,830 people reported to have side effects when taking Valproic acid.
Among them, 42 people (0.12%) have Monocyte count increased.

Among these 42 people:
What is the gender of people who have Monocyte count increased when taking Valproic acid? *
- female: 73.68 %
- male: 26.32 %
What is the age of people who have Monocyte count increased when taking Valproic acid? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 12.5 %
- 20-29: 31.25 %
- 30-39: 12.5 %
- 40-49: 6.25 %
- 50-59: 25.0 %
- 60+: 12.5 %
What are other drugs people take besides Valproic acid? *
- Clozaril: 29 people, 69.05%
- Lorazepam: 24 people, 57.14%
- Lactulose: 23 people, 54.76%
- Aripiprazole: 23 people, 54.76%
- Pantoprazole: 5 people, 11.90%
- Clozapine: 4 people, 9.52%
- Zyprexa: 2 people, 4.76%
- Tamsulosin: 2 people, 4.76%
- Amisulpride: 2 people, 4.76%
- Sertraline: 2 people, 4.76%
What are other side effects people have besides Monocyte count increased? *
- Neutrophil Count Increased (excess than normal number of neutrophil a type of blood cell): 31 people, 73.81%
- Red Blood Cell Count Decreased: 28 people, 66.67%
- White Blood Cell Count Increased: 27 people, 64.29%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 27 people, 64.29%
- White Blood Cell Count Decreased: 25 people, 59.52%
- Lymphocyte Count Decreased: 25 people, 59.52%
- Mean Cell Haemoglobin Increased (more than normal haemoglobin per red blood cell in a sample of blood): 23 people, 54.76%
- Leukaemia (blood or bone marrow cancer): 21 people, 50.00%
- Thrombocytopenia (decrease of platelets in blood): 17 people, 40.48%
- Haemoglobin Decreased: 7 people, 16.67%
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 31 people, 73.81%
- Schizoaffective Disorder (a mental disorder characterized by disordered thought): 3 people, 7.14%
- Affective Disorder (mental disorder): 2 people, 4.76%
- Schizophrenia, Paranoid Type (delusions and auditory hallucinations but relatively normal intellectual functioning and expression of affect): 1 person, 2.38%
- Psychotic Disorder: 1 person, 2.38%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 2.38%
- Impulsive Behavior: 1 person, 2.38%
- Delusion (a false belief or opinion): 1 person, 2.38%
- Autism (a mental condition, present from early childhood, characterized by difficulty in communicating and forming relationships with other people and in using language and abstract concepts): 1 person, 2.38%
- Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 2.38%
* Approximation only. Some reports may have incomplete information.
Do you take Valproic acid and have Monocyte count increased?
- Check whether Monocyte count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Valproic acid:
- Valproic acid (36,193 reports)
Monocyte count increased treatments and more:
- Monocyte count increased (5,160 reports)
How severe was Monocyte count increased and when was it recovered:
Expand to all the drugs that have ingredients of valproic acid:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Valproic acid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Monocyte count increased:
- Monocyte count increased (604 drugs)
Browse all the conditions that are associated with Monocyte count increased:
- Monocyte count increased (690 conditions)
Related publications that referenced our studies
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
- Gupta E, Kunjal R, Cury JD, "Severe hyponatremia due to valproic acid toxicity", Journal of clinical medicine research, 2015 Jan .
- Hwabejire JO, Lu J, Liu B, Li Y, Halaweish I, Alam HB, "Valproic acid for the treatment of hemorrhagic shock: a dose-optimization study", journal of surgical research, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on valproic acid (the active ingredients of Valproic acid) and Valproic acid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Mucinex and Valacyclovir Hydrochloride - 10 seconds ago
- Could Carbamazepine cause Mouth Haemorrhage? - 26 seconds ago
- Could Zestril cause Muscle Weakness Aggravated? - 31 seconds ago
- Drug interactions of Percocet and Zovirax - 31 seconds ago
- Drug interactions of Warfarin Sodium and Lutein - 31 seconds ago
- Could Xarelto cause Cyst? - 33 seconds ago
- Drug interactions of Halcion and Escitalopram - 36 seconds ago
- Could Actemra cause Terminal State? - 48 seconds ago
- Could Kaletra cause Herpes Zoster? - 57 seconds ago
- Could Metoprolol Succinate cause Bronchitis? - a minute ago